Intelligence Platform

Patents

Browse 389 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8278100

Lasonolide compounds as reagents for inducing premature chromosome condensation and method

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278083

Inactivated influenza virus compositions

granted patent

US 8273797

Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehy

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268323

Conformationally stabilized HIV envelope immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263091

Method of treating and preventing infections in immunocompromised subjects with immunostim

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8257915

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252550

Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252538

MicroRNA expression signature for predicting survival and metastases in hepatocellular car

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8247183

Compositions and methods for diagnosis and treatment of tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8247228

Method of inducing memory B cell development and terminal differentiation

granted patent

US 8236313

Prevention of tissue ischemia, related methods and compositions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8232379

Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8232259

Multiple CpG oligodeoxynucleotide and their use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227446

Oligodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227438

Suppressors of CpG oligonucleotides and methods of use

granted patent

US 8221768

Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8222225

Method of treating pneumoconiosis with oligodeoxynucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8216565

GP100-specific T cell receptors and related materials and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8207142

Inhibitor of DNA methylation

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8198244

Regulation of skin characteristics by DICKKOPF1 (DKK1)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8188214

Brachyury polypeptides and methods for use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173135

Methods for preparing complex multivalent immunogenic conjugates

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168202

Hexavalent bovine rotavirus reassortant composition designed for use in developing countri

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163545

Vaccine against pandemic strains of influenza viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted